| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,609 |
3,322 |
$261K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,450 |
1,223 |
$67K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,830 |
2,004 |
$22K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
606 |
484 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,509 |
633 |
$15K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,930 |
1,538 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
2,228 |
1,771 |
$3K |
| 87420 |
|
114 |
91 |
$967.80 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
149 |
114 |
$888.85 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
608 |
444 |
$837.04 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
14 |
13 |
$741.07 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18 |
13 |
$477.60 |
| 86328 |
|
18 |
13 |
$442.66 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
55 |
41 |
$352.98 |
| 86308 |
|
75 |
60 |
$258.39 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
841 |
646 |
$249.58 |
| J0945 |
Injection, brompheniramine maleate, per 10 mg |
95 |
65 |
$144.31 |
| 80053 |
Comprehensive metabolic panel |
12 |
12 |
$91.67 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
90 |
68 |
$60.82 |